Three Unstoppable Dividend Stocks for Your Portfolio

Three analysts from The Motley Fool have compiled a list of healthcare stocks that are ideal for investors seeking stable dividends. These companies are distinguished by an impressive track record and solid future prospects. David Jagielski highlighted Abbott Laboratories. The company, which has been paying dividends for over a century and has increased them consecutively for 52 years, is compelling due to its diversified business structure. This allows it to distribute stable dividends in the future. With business units in the pharmaceutical, nutrition, medical device, and diagnostics sectors, Abbott recently achieved organic growth of over 9%, aside from the fluctuations caused by COVID-19. Amgen, presented by Prosper Junior Bakiny, is a leading biotechnology company with an impressive track record of innovation. Its pipeline, particularly in the weight loss segment, attracts significant investor interest. Although Amgen's organic revenue growth has been moderate over the past three years, its dividend development is remarkable: payouts have been increased by 55% over the last five years. This, along with the solid pipeline, suggests further growth prospects for the future. Keith Speights emphasized the advantages of AbbVie, a company that was spun off from Abbott in 2013. Despite losing US patent rights for its blockbuster drug Humira at the beginning of 2023, AbbVie is seeing sharply rising revenues from new autoimmune drugs such as Rinvoq and Skyrizi. Additionally, AbbVie has a promising pipeline with over 90 development programs in the fields of oncology, immunology, and neurology.